Figure 2: Typical immunophenotype of a CVID-AcT patient.

Gating strategy for B and T-cell analysis (A), with relevant B and CD4+ T cell subsets displayed in healthy donor (B) and in CVID AcT patient (C), gates used for simplified definition are highlighted in red.